CDKN3 and breast cancer: For example, elevated Sp3 levels have been shown to promote pancreatic and breast cancer cell growth by inhibiting transcription of growth inhibitory genes including thosse encoding the cyclin-dependent kinase inhibitor p27 and the type II receptor for transforming growth factor-β [8,51].